These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24817035)

  • 1. The histamine H₄ receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects.
    Kollmeier A; Francke K; Chen B; Dunford PJ; Greenspan AJ; Xia Y; Xu XL; Zhou B; Thurmond RL
    J Pharmacol Exp Ther; 2014 Jul; 350(1):181-7. PubMed ID: 24817035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis.
    Murata Y; Song M; Kikuchi H; Hisamichi K; Xu XL; Greenspan A; Kato M; Chiou CF; Kato T; Guzzo C; Thurmond RL; Ohtsuki M; Furue M
    J Dermatol; 2015 Feb; 42(2):129-39. PubMed ID: 25491792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and preclinical characterization of the histamine H(4) receptor antagonist JNJ-39758979.
    Thurmond RL; Chen B; Dunford PJ; Greenspan AJ; Karlsson L; La D; Ward P; Xu XL
    J Pharmacol Exp Ther; 2014 May; 349(2):176-84. PubMed ID: 24549371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of a H₄ receptor antagonist in humans: a milestone in histamine research.
    Seifert R
    J Pharmacol Exp Ther; 2014 Jul; 350(1):2-4. PubMed ID: 24925898
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the antihistamine effects of olopatadine and levocetirizine during a 24-h period: a double-blind, randomized, cross-over, placebo-controlled comparison in skin responses induced by histamine iontophoresis.
    Takeo T; Kasugai C; Tanaka R; Ando T; Ogawa A; Akita Y; Watanabe D
    J Dermatol; 2013 Dec; 40(12):987-92. PubMed ID: 24303975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours.
    Purohit A; Melac M; Pauli G; Frossard N
    Ann Allergy Asthma Immunol; 2004 Jun; 92(6):635-40. PubMed ID: 15237765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
    Grant JA; Riethuisen JM; Moulaert B; DeVos C
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
    Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-four hours of activity of cetirizine and fexofenadine in the skin.
    Purohit A; Duvernelle C; Melac M; Pauli G; Frossard N
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):387-92. PubMed ID: 11345280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar rapid onset of action and magnitude of effect of fexofenadine and cetirizine as assessed by inhibition of histamine-induced wheal-and-flare reaction.
    Purohit A; N'Gom AS; Deslandes B; Pauli G; Frossard N
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):562-7. PubMed ID: 15609766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges.
    Gispert J; Antonijoan R; Barbanoj M; Gich I; Garcia E; Esbrí R; Luria X
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):259-64. PubMed ID: 12269645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin.
    Denham KJ; Boutsiouki P; Clough GF; Church MK
    Inflamm Res; 2003 Oct; 52(10):424-7. PubMed ID: 14520518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopic and healthy subjects.
    Fadel R; Ramboer I; Chatterjee N; Rihoux JP; Derde MP
    Allergy; 2000 Sep; 55(9):888-91. PubMed ID: 11003455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopic and healthy subjects.
    Fadel R; Ramboer I; Chatterjee N; Rihoux JP; Derde MP
    Allergy; 2000 Apr; 55(4):382-5. PubMed ID: 10782524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistency of the efficacy of cetirizine and ebastine on skin reactivity.
    Frossard N; Melac M; Benabdesselam O; Pauli G
    Ann Allergy Asthma Immunol; 1998 Jan; 80(1):61-5. PubMed ID: 9475569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proof-of-concept study of the effect of a novel H3-receptor antagonist in allergen-induced nasal congestion.
    Barchuk WT; Salapatek AM; Ge T; D'Angelo P; Liu X
    J Allergy Clin Immunol; 2013 Oct; 132(4):838-46.e1-6. PubMed ID: 23791513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative activity of cetirizine and mizolastine on histamine-induced skin wheal and flare responses at 24 h.
    Purohit A; Mélac M; Pauli G; Frossard N
    Br J Clin Pharmacol; 2002 Mar; 53(3):250-4. PubMed ID: 11874388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24 h period: a double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresis.
    Takahashi H; Zhang Y; Morita E
    Arch Dermatol Res; 2008 Jul; 300(6):291-5. PubMed ID: 18305947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Development of Histamine H
    Thurmond RL; Venable J; Savall B; La D; Snook S; Dunford PJ; Edwards JP
    Handb Exp Pharmacol; 2017; 241():301-320. PubMed ID: 28233185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.